100 % Datengenauigkeit
Wissenschaftlicher Support rund um die Uhr
0 % Toleranz bei der Produktqualität
Lagerstandorte
- New Jersey, USA
- Czech Republic, EU
- Mumbai, India
* Vorbehaltlich Verfügbarkeit
Dokumentation
Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.
127252-80-6Clarithromycin EP Impurity O
● Auf Lager
| Katalog-Nr.:: | VL740015 |
|---|---|
| CAS-Nr.:: | 127252-80-6 |
| Summenformel:: | C39H72N2O13 |
| Molare Masse:: | 776.99 g/mol |
Zusätzliche Informationen zu CAS 127252-80-6
Parent drug
ClarithromycinIUPAC-Name
6-O-Methylerythromycin A (Z)-9-(O-methyloxime)Synonyme
Clarithromycin (9Z)-O-MethyloximeBeschreibung
Clarithromycin EP Impurity O (CAS No: 127252-80-6) or 6-O-Methylerythromycin A (Z)-9-(O-methyloxime) is a chemical modification of erythromycin. Erythromycin is a macrolide that functions by blocking the translocation reaction at the time of protein synthesis. Erythromycin, except under alkaline conditions, is inactive against Enterobacteriaceae and Pseudomonas aeruginosa.References
WATANABE, YOSHIAKI, et al. “Chemical Modification of Erythromycins. IX. Selective Methylation at the C-6 Hydroxyl Group of Erythromycin a Oxime Derivatives and Preparation of Clarithromycin.†The Journal of Antibiotics, vol. 46, no. 4, 1993, pp. 647–60, https://doi.org/10.7164/antibiotics.46.647. WASHINGTON, JOHN A., and WALTER R. WILSON. “Erythromycin: A Microbial and Clinical Perspective after 30 Years of Clinical Use (First of Two Parts).†Mayo Clinic Proceedings, vol. 60, no. 3, Mar. 1985, pp. 189–203, https://doi.org/10.1016/s0025-6196(12)60219-5. ‌Angebot anfordern
„*“ zeigt erforderliche Felder an
Other products related to Clarithromycin impurities
Verunreinigungsstruktur
Name der Muttersubstanz
CAS-Nr.:
Name der Verunreinigung
Katalog-Nr.:
Clarithromycin
CAS No. 81103-11-9
Cat No. VE0027697
